$Principia Biopharma Inc.(PRNB)$Principia Biopharma Inc. is a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology. Their proprietary Tailored Covalency platform enables us to design and develop reversible covalent and irreversible covalent, small molecule inhibitors with potencies and selectivities that they believe will rival those of injectable biologics, yet maintain the convenience of a pill.